On April 11, 2024, Nectero Medical LLC closed the transaction. The company raised $96,000,000 in a round of funding led by new investor NVP Associates, LLC with participation from new investors BioStar Ventures LLC, Cadence Healthcare Ventures, Llc, Aphelion Capital, LLC, returning investor Boston Scientific Corporation and other investors. The round was oversubscribed.

Dr. Zack Scott of NVP Associates, LLC and Dr. Alan Davis of BioStar Ventures LLC will join the company's board. The company has received $32,791,551 and included participation from 30 investors pursuant to exemption provided under Regulation D.